Compared

Kaypo vs Chorus.

The short answer

Chorus, part of ZoomInfo, records and analyzes sales calls. Kaypo scores every open deal from what the buyer did, proves the score against the deals you have already closed, and sends each rep a morning Slack message naming what moved and why.

How Kaypo answers this on your pipeline

30 minutes with the founder

See how Kaypo helps your pipeline

Thirty minutes on your pipeline or the example one. Pick a time and it is booked.

Chorus and Kaypo, side by side

Chorus

conversation intelligence

  • Call recording, deal boards and coaching at enterprise scale.
  • Pricing is set by the vendor. Check its current plans against your team size.

Kaypo

Deal scoring, signals and routing, proven on your own wins

  • One price at $1,500 a month, or $15,000 a year, for one admin and up to 15 users.
  • Scores each open deal from what the buyer did, with every weight visible and editable.
  • Proves the score against your own closed deals and reports when the benchmark was better.
  • A morning Slack message with the reason beside the number.

Should you choose Chorus or Kaypo?

Kaypo turns a transcript into signals on a deal and keeps no recordings. Most teams end up running both rather than choosing.

How Kaypo answers this for your pipeline

Every open deal, scored on what the buyer did, with the move that worked in your own wins.

Kaypo reads your CRM, email and calls, checks every signal against the deals you have already won and lost, and puts the answer on each deal: the score, why it moved, and the next step with the email written.

Questions people ask

Is Kaypo a Chorus alternative?

Only partly. Chorus, part of ZoomInfo, records and analyzes sales calls. Kaypo scores open deals and delivers a morning reading, so the two solve different problems and often sit side by side.

Is Kaypo cheaper than Chorus?

Kaypo is $1,500 a month, or $15,000 a year, for one admin and up to 15 users, published, with no implementation fee. Whether that is cheaper depends on what you need and how many people would use it.

Reviewed November 8, 2026 against the product as it behaves today.